Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Every patient takes a different path to relief. Medtronic offers choices of neuromodulation therapies so clinicians can find the best treatment for every patient.
Sacral neuromodulation (SNM) uses mild electrical stimulation of the sacral nerve to influence the pelvic floor muscles (for bladder control2) as well as the anal sphincter and bowel (for bowel control3).FIND OUT MORE
Percutaneous tibial neuromodulation (PTNM) restores bladder function* without the side effects of medication† or the potential need to self-catheterize.1FIND OUT MORE
Get what you need to achieve the best possible outcomes with maximum efficiency.FIND RESOURCES
Collaborate with us to help more of your patients find and sustain relief.MANAGE YOUR PRACTICE
The smart programmer allows clinicians to customize programming in the clinic and patients to manage their experience easily at home or on-the-go.EXPLORE THE SMART PROGRAMMER
Neuromodulation therapies from Medtronic are backed by extensive clinical evidence along with the experience of hundreds of thousands of patients.SEE THE EXPERIENCE
From prospective patients to those living with our therapies, we provide end-to-end support for patients with bladder and bowel control problems.LEARN MORE
Get the latest updates about neuromodulation therapies, solutions, and events.SIGN UP NOW
Follow Medtronic Pelvic Health on Twitter for the latest updates on our products and therapies.FOLLOW US ON TWITTER
Learn about the opportunities for treating OAB and other pelvic floor disorders with neuromodulation.FIND RESOURCES
Keep current patients in your practice by maximizing engagement with every visit.MANAGE YOUR PRACTICE
Increase patient awareness in your local community.MARKETING TOOLS FOR YOUR PRACTICE
Restored bladder function is defined as a measurable reduction in urinary frequency and/or urinary incontinence episodes following treatment.
The most common side effects are temporary and include mild pain or skin inflammation at or near the stimulation site.
Peters, K. M., S. A. Macdiarmid, et al. (2009). "Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial." J Urol 182(3): 1055-1061.
Chancellor MB, Chartier-Kastler EJ. Principles of sacral nerve stimulation (SNS) for the treatment of bladder and urethral sphincter dysfunctions. Neuromodulation. 2000;3(1):15-26.
Gourcerol G, Vitton V, Leroi AM, et al. How sacral nerve stimulation works in patients with faecal incontinence. Colorectal Dis. 2011;13(8):e203-211.
While the NURO™ device was not used in this study, since it delivers equivalent stimulation therapy as the device used in the study, a user can expect similar performance.